LEMAITRE VASCULAR, INC. (LMAT) Net margin 2016–2025
LEMAITRE VASCULAR, INC. (LMAT) net profit margin by fiscal year — reported net income divided by reported revenue.
23.1%FY2025 · since FY2016: 11.9% → 23.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 23.1% | +3.1 pp |
| FY2024 | 20.0% | +4.5 pp |
| FY2023 | 15.6% | +2.8 pp |
| FY2022 | 12.8% | -4.7 pp |
| FY2021 | 17.4% | +1.0 pp |
| FY2020 | 16.4% | +1.1 pp |
| FY2019 | 15.3% | -6.4 pp |
| FY2018 | 21.7% | +4.7 pp |
| FY2017 | 17.0% | +5.2 pp |
| FY2016 | 11.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More LMAT financial trends
LMAT RevenueLMAT Net incomeLMAT Gross profitLMAT Gross marginLMAT Operating incomeLMAT Operating marginLMAT Operating cash flowLMAT Free cash flowLMAT Capital expendituresLMAT Return on equityLMAT Stock buybacksLMAT Dividends paidLMAT Total assetsLMAT Total liabilitiesLMAT Shareholders’ equityLMAT overview →